Drug Delivery System– tag –
-
Penn Engineering Develops LNP-Based ‘One-Two Punch’ to Transform Oral Cancer Treatment: Co-Delivering p53 & Ciclopirox Significantly Reduces Tumor Burden in Resistant Models
Penn Engineering (University of Pennsylvania) USA Overview Researchers at Penn have developed a lipid nanoparticle (LNP) formulation to co-deliver two drugs, p53 and ciclopirox, for oral cancer treatment. This LNP platform aims to simult... -
Advances in LNP-Mediated Nucleic Acid Delivery to Respiratory & GI Mucosa: AI Integration for Personalized DDS Future
MDPI Switzerland Overview Lipid nanoparticles (LNPs) are rapidly advancing as a versatile platform to overcome delivery barriers for nucleic acids to respiratory and gastrointestinal mucosal sites. LNPs offer tunable physicochemical prop... -
First PROTAC Approval Validates Targeted Protein Degradation as a Breakthrough Modality for Cancer Treatment
Converge Bio Unknown Overview The FDA approval of vepdegestrant, developed by Arvinas and Pfizer, signifies a major milestone for targeted protein degradation (TPD). This first-in-class PROTAC, approved for ER+/HER2-, ESR1-mutated advanc... -
Exosome Therapeutics Firm Unveils Advanced Platform, Pipeline Progress Targeting Regenerative Medicine and Enhanced Drug Delivery
Company Disclosures USA Overview An exosome-based therapeutics company has detailed significant pipeline advancements and its cutting-edge technology platform at a recent investor briefing. The presentation particularly emphasized exosom... -
Ultra-Homotypic Targeting: Lanthanide-Modified EVs Boost Cancer Detection Sensitivity by Over 25-Fold
University of Tokyo Japan Overview Researchers at the University of Tokyo, led by Professor Keisuke Goda, have unveiled a groundbreaking 'ultra-homotypic targeting' technology. By engineering extracellular vesicles (EVs) with lanthanide ... -
Drug Discovery & DDS Weekly Report July 26, 2026
▼ ▼ ▼ If the infographic makes you want to read the full report, please click the download button below. ▼ ▼ ▼ 🎙 Podcast July 26, 2026 (MP3) — Play & Download DrugDiscovery_DDSEnglishPodcast_20260726.mp3Download View Past Weekly Reports→ -
Blood-Brain Barrier Drug Delivery Summit (B3DD) Convenes to Overcome CNS Therapeutic Hurdles
News-Medical.net USA Overview The Blood-Brain Barrier Drug Delivery Summit (B3DD) addressed critical challenges in CNS drug delivery, focusing on bypassing the brain's selective permeability. Advanced DDS research into nanoparticles, lip... -
UT MD Anderson Tackles Brain Tumor Therapy by Advancing Multiple Blood-Brain Barrier Penetration Strategies
UT MD Anderson Cancer Center USA Overview Researchers at UT MD Anderson Cancer Center are aggressively pursuing multiple research strategies to overcome the blood-brain barrier (BBB), a formidable challenge in brain tumor treatment. Whil... -
Drug Discovery & DDS Weekly Report July 19, 2026
▼ ▼ ▼ If the infographic makes you want to read the full report, please click the download button below. ▼ ▼ ▼ 📄 Weekly Report July 19, 2026 (PDF) — Download Weekly Report July 19, 2026 (PDF) — DownloadDownload 🎙 Podcast July 19, 2026 (... -
Oregon State University Develops Novel Sugar-Coated Nanoparticle Therapy for Glioblastoma: Boosting Mouse Survival by 50%
Oregon State University via Medical Xpress USA Overview Researchers at Oregon State University have developed a new experimental glioblastoma treatment using sugar-coated nanoparticles to deliver genetic instructions that restore a tumor...
